Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A large study found that monolayers were superior in detecting cancer.

2.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

3.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

4.

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

5.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot